Avexa Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
11,869.00
3,516.00
1,135.00
441.20
1,008.20
1,186
Total Accounts Receivable
2,077.00
1,828.00
408.00
322.30
598.20
814.90
Other Current Assets
47.00
46.00
41.00
15.90
1.30
14.20
Total Current Assets
13,993.00
5,390.00
1,584.00
779.40
1,607.70
2,015.10
Net Property, Plant & Equipment
20.00
23.00
17.00
10.40
51.80
65.70
Total Investments and Advances
-
4,158.00
5,050.00
-
-
-
Long-Term Note Receivable
-
2,352.00
-
-
-
-
Intangible Assets
-
-
-
1,035.50
872.60
1,839.10
Total Assets
14,013.00
11,923.00
6,651.00
1,825.30
2,532.10
3,919.80
Accounts Payable
279.00
254.00
199.00
253.30
200.60
Other Current Liabilities
183.00
185.00
78.00
77.50
66.20
Total Current Liabilities
462.00
439.00
277.00
330.80
266.80
Provision for Risks & Charges
12.00
13.00
-
-
0.80
Total Liabilities
474.00
452.00
277.00
330.80
267.60
Common Equity (Total)
13,539.00
11,471.00
6,374.00
1,494.50
2,264.60
Total Shareholders' Equity
13,539.00
11,471.00
6,374.00
1,494.50
2,264.60
Total Equity
13,539.00
11,471.00
6,374.00
1,494.50
2,264.60
Liabilities & Shareholders' Equity
14,013.00
11,923.00
6,651.00
1,825.30
2,532.10

About Avexa

View Profile
Address
Level 5
Cremorne Victoria (VIC) 3121
Australia
Employees -
Website http://www.novitahealthcare.com.au
Updated 07/08/2019
Novita Healthcare Ltd. is a medical technology company which focuses on the development of the TALI Technology, a tablet based software application that assess and treat childhood attention difficulties. It operates through the Research and Development, and Investments segments. The Research and Development segment engages in the operation of conducting health and medical research and development for commercialization.